A. Ruhlmann, et al, “Effects of the Immunosuppressive Drugs CsA and FK 506 on Intracellular Signalling and Gene Regulation,” Immunobiol., 198, pp. 192-206, 1997. |
S.L. Schreiber, et al, “Molecular Recognition of Immunophilins and Immunophilin-Ligand Complexes,” Tetrahedron, 48(13), pp. 2545-2558, 1992. |
T. Wang, et al, “Specific Interaction of Type I Receptors of the TGF-β Family with the Immunophilin FKBP-12,” Science, 265, pp. 674-676, 1994. |
A.M. Cameron, et al, “FKBP12 Binds the Inositol 1,4,5-Trisphosphate Receptor at Leucine-Proline (1400-1401) and Anchors Calcineurin to this FK506-Like Domain,” J. Biol. Chem., 272(44), pp. 27582-27588, 1997. |
T. Wang, et al, “The Immunophilin FKPB12 Functions as a Common Inhibitor of the TGFβ Family Type I Receptors,” Cell, 86, pp. 435-444, 1996. |
D.S. Yamashita, et al, “Design, Synthesis and Evaluation of Dual Domain FKBP Ligands,” Bioorg. Med. Chem. Lett., 4(2), pp. 325-328, 1994. |
D.M. Armistead, et al, “Design, Synthesis and Structure of Non-Macrocyclic Inhibitors of FKBP12, the Major Binding Protein for the Immunosuppressant FK506,” Acta Cryst. D., 51, pp. 522-528, 1995. |
W.E. Lyons, et al, “Immunosuppressant FK506 Promotes Neurite Outgrowth in Cultures of PC12 Cells and Sensory Ganglia,” Proc. Natl. Acad. Sci. USA, 91, pp. 3191-3195, 1994. |
B.G. Gold, et al, “The Immunosuppressant FK506 Increases the Rate of Axonal Regeneration in Rat Sciatic Nerve,” J. Neuroscience, 15(11), pp. 7509-7516, 1995. |
G.S. Hamilton, et al, “Neuroimmunophilin Ligands as Novel Therapeutics for the Treatment of Degnerative Disorders of the Nervous System,” Curr. Pharm. Design, 3, pp. 405-428, 1997. |
B.G. Gold, et al, “A Nonimmunosuppressant FKPB-12 Ligand Increases Nerve Regeneration,” Exp. Neurology, 147, pp. 269-278, 1997. |
S.H. Snyder, et al, “Immunophilins and the Nervous System,” Nature Medicine, 1(1), pp. 32-37, 1995. |
B.G. Gold, et al, “the Immunosuppressant FK506 Increases GAP-43 mRNA Levels in Azotomized Sensory Neurons,” Neuroscience Letters, 241, pp. 25-28, 1998. |
J.L. Kofron, et al, “Determination of Kinetic Constants for Peptidyl Prolyl Cis-Trans Isomerases by an Improved Spectrophotometric Assay,” Biochemistry, 30, pp. 6127-6134, 1991. |
U.A. Germann, et al, “Cellular and Biochemical Characterization of VX-710 as a Chemosensitizer: Reversal of P-Glycoprotein-Mediated Multidrug Resistance In Vitro,” Anti-Cancer Drugs, 8, pp. 125-140, 1997. |
J.R. Hauske, et al, “Investigation of the Effects of Synthetic, Non-Cytotoxic Immunophilin Inhibitors on MDR,” Bioorg. Med. Chem. Lett., 4(17), pp. 2097-2102, 1994. |
M.M. Endrich, et al, “The V3 Loop of Human Immunodeficiency Virus Type-1 Envelope Protein is a High-Affinity Ligand for Immunophilins Present in Human Blood,” Eur. J. Biochem., 252, pp. 441-446, 1998. |
A. Karpas, et al, “Inhibition of Human Immunodeficiency Virus and Growth of Infected T Cells by the Immunosuppressive Drugs Cyclosporin A and FK506,” Proc. Natl. Acad. Sci. USA, 89, pp. 8351-8355, 1992. |